CCL22 signaling contributes to sorafenib resistance in...

Pharmacological Research 2020 / 07 Vol. 157

CCL22 signaling contributes to sorafenib resistance in hepatitis B virus-associated hepatocellular carcinoma

Gao, Yanan, Fan, Xing, Li, Nan, Du, Chengzhi, Yang, Bin, Qin, Wenhao, Fu, Jing, Markowitz, Geoffrey J., Wang, Hongyang, Ma, Jianli, Cheng, Shuqun, Yang, Pengyuan
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
157
Journal:
Pharmacological Research
DOI:
10.1016/j.phrs.2020.104800
Date:
July, 2020
File:
PDF, 335 KB
2020
Conversion to is in progress
Conversion to is failed